SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/2E77AAC3C2597A04B80779460CBF0C67A84426FAAB6EE89DB6153A448F15D1B17310DA65259063A99DCDACFC56B852A7>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/2E77AAC3C2597A04B80779460CBF0C67A84426FAAB6EE89DB6153A448F15D1B17310DA65259063A99DCDACFC56B852A7
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/2E77AAC3C2597A04B80779460CBF0C67A84426FAAB6EE89DB6153A448F15D1B17310DA65259063A99DCDACFC56B852A7
http://www.w3.org/2000/01/rdf-schema#comment
"Not all severe abacavir-induced adverse events occur as a result of classic hypersensitivity reactions and can present also in HLA-B*5701-negative patients."
xsd:string
http://purl.uniprot.org/uniprot/#_336056B67D5032C2F16A5A3DBB96106956A339C248F00E3EFC59A49894328F7579C09A73FBDE77746F354C8915D7C41C
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/2E77AAC3C2597A04B80779460CBF0C67A84426FAAB6EE89DB6153A448F15D1B17310DA65259063A99DCDACFC56B852A7
http://purl.uniprot.org/uniprot/C6K6H9
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/2E77AAC3C2597A04B80779460CBF0C67A84426FAAB6EE89DB6153A448F15D1B17310DA65259063A99DCDACFC56B852A7
http://purl.uniprot.org/uniprot/#_C6K6H9-mappedCitation-19304978
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/2E77AAC3C2597A04B80779460CBF0C67A84426FAAB6EE89DB6153A448F15D1B17310DA65259063A99DCDACFC56B852A7